{
    "sections": [
        {
            "title": "Clinical Significance",
            "requirement_evaluations": [
                {
                    "requirement_id": "R1",
                    "applicable": true,
                    "applicability_reasoning": "Applicable because the section discusses diseases and conditions resulting from mutations or expression changes in the ANLN gene.",
                    "score": 1.0,
                    "confidence": 0.95,
                    "evidence": "The section mentions ANLN's involvement in various cancers and other diseases such as focal segmental glomerulosclerosis and branchio-otic syndrome.",
                    "reasoning": "The section clearly lists conditions associated with ANLN mutations and overexpression.",
                    "overlap_notes": "No significant overlap in disease listing elsewhere."
                },
                {
                    "requirement_id": "R4",
                    "applicable": true,
                    "applicability_reasoning": "Applicable because the section cites studies on the clinical implications of ANLN.",
                    "score": 0.75,
                    "confidence": 0.85,
                    "evidence": "Reference to studies like Liu2022Pan-cancer and Suzuki2005ANLN are made in relation to ANLN's significance.",
                    "reasoning": "While the section discusses various studies, it could further break down the results of these studies to improve clarity and depth.",
                    "overlap_notes": "Focus on clinical significance without redundancy from other sections."
                }
            ],
            "meta_notes": "The section effectively presents ANLN's clinical significance but could enhance the depth of study descriptions."
        }
    ]
}